SG Americas Securities
LJPC

SG Americas Securities’s La Jolla Pharmaceutical Company LJPC Stock Holding History

SG Americas Securities’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,064
Closed -$51K – 3855
2020
Q2 		$51K Buy
+12,064
New +$73.5K ﹤0.01% 3532
2020
Q1 		– Sell
-195,929
Closed -$770K – 3825
2019
Q4 		$770K Sell
195,929
-180,057
-48% -$1.06M 0.01% 1456
2019
Q3 		$3.31M Buy
375,986
+299,995
+395% +$2.83M 0.03% 638
2019
Q2 		$703K Buy
+75,991
New +$573K ﹤0.01% 1672
2018
Q2 		– Sell
-4,513
Closed -$134K – 3742
2018
Q1 		$134K Buy
+4,513
New +$146K ﹤0.01% 2727
2017
Q2 		– Sell
-6,538
Closed -$195K – 3820
2017
Q1 		$195K Buy
+6,538
New +$167K ﹤0.01% 2457

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

SG Americas Securities's LJPC Position: Q3 2020 in Review

SG Americas Securities sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2020, closing a stake of 12,064 shares — an estimated $51K sold.

SG Americas Securities first reported a position in LJPC in Q1 2017 and held it in 6 quarters. The position peaked at $3.31M in Q3 2019. 64 funds tracked by Wall St. Rank hold LJPC as of Q3 2020.

  • SG Americas Securities reported no remaining La Jolla Pharmaceutical Company position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 12,064 La Jolla Pharmaceutical Company shares in Q3 2020, an estimated $51K.
  • SG Americas Securities first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 6 quarters.
  • SG Americas Securities's La Jolla Pharmaceutical Company position peaked at $3.31M in Q3 2019.
  • 64 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.